Sungcad, Analyn E.
HRN: 18-26-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/07/2026
CEFUROXIME 500MG (TAB)
07/07/2026
07/14/2026
PO
500mg
BID
S/p Pelvic Lap
Checking Initial Appropriateness
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines